MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    The Link between Handedness and Prevalence of Musician’s Dystonia – A Systematic Literature Review

    S. Ouennane, S. Alici, M. Tiihonen, M. Butz (Duesseldorf, Germany)

    Objective: The link between handedness and the prevalence of musician’s dystonia has not been investigated yet. In this review potential differences in handedness distribution between…
  • 2023 International Congress

    Real-world effectiveness and safety of deutetrabenazine in patients with chorea associated with Huntington disease

    V. Sung, A. White, H. Romdhani, D. Goldschmidt, R. Ayyagari, N. Chaijale, A. Yaari, M. Gordon, J. Logan, A. Yang, R. Ribalov (Birmingham, USA)

    Objective: To assess real-world effectiveness and safety of deutetrabenazine (DTBZ) for chorea associated with Huntington disease (HD). Background: Real-world evidence on the impact of DTBZ…
  • 2023 International Congress

    Trajectories of Physical Performance in Prodromal and Early Parkinson’s Disease

    M. Bock, K. Covinsky, E. Vittinghoff, C. Tanner, K. Yaffe (San Francisco, USA)

    Objective: To describe trajectories of physical performance in prodromal and early Parkinson’s Disease (PD). Background: There is a need to better characterize the prodromal and…
  • 2023 International Congress

    Detailed illustration of a Turkish patient with homozygous C19ORF12 mutation

    H. Onder, T. Comoglu, S. Comoglu (Ankara, Turkey)

    Objective: To illustrate a rare Turkish patient with homozygous C19ORF12 mutation and discuss limitations regarding the current terminology and classification. Background: Neurodegeneration with brain iron…
  • 2023 International Congress

    miRNAs from blood serum as an early diagnostic biomarker for Parkinson’s disease: A study in an animal model

    MD. Ahmad, PSD. Dholaniya (Hyderabad, India)

    Objective: This work aims to elucidate miRNA-based biomarkers for the early stages of Parkinson`s Disease diagnosis in a chemically induced PD rat model. Background: The…
  • 2023 International Congress

    Network localization of limb ataxia

    J. Pullinen, O. Liesmäki, O. Likitalo, A. Bellmunt Gil, J. Aaltonen, E. Mäkinen, E. Ellis, P. Ylikotila, J. Joutsa (Turku, Finland)

    Objective: To identify the neural substrates of limb ataxia caused by stroke lesions. Background: Ataxia is a neurological sign defined by incoordination of voluntary movements.…
  • 2023 International Congress

    Baseline characteristics for patients with multiple system atrophy entering a randomized, controlled study of the anti-α-synuclein monoclonal antibody Lu AF82422

    W. Singer, A. Takeda, L. Kjærsgaard, J. Wiedemann, A. Berger, A. Varrone, A. Bidani, D. Meulien (Rochester, USA)

    Objective: Report baseline characteristics for patients with multiple system atrophy (MSA) entering a study to assess the safety and efficacy of alpha-synuclein (α-syn) monoclonal antibody…
  • 2023 International Congress

    Frequency of Parkinson disease following COVID-19 infection: a two-year retrospective cohort study

    A. Wang, J. Perez, S. Gunzler (Cleveland, USA)

    Objective: We aimed to utilize a large healthcare research network to determine the risk of developing Parkinson disease following COVID-19 infection compared individuals without COVID-19…
  • 2023 International Congress

    Reliability of brainsense technology as compared to SoC in STN DBS programming

    I. Avilés-Olmos, L. Gonzalez-Quarante, A. Arcadi, P. Clavero, MC. Rodriguez-Oroz, M. Valencia, M. Alegre (Pamplona, Spain)

    Objective: We aimed to study coincidence between the contact selected at programming session by experienced neurologists at 6months follow up after bilateral STN DBS (considered…
  • 2023 International Congress

    Genome-wide association identifies novel etiological insights associated with Parkinson’s Disease in African and African admixed populations

    M. Rizig, S. Bandres Ciga, M. Makarious, O. Ojo, O. Okunoye, K. Levine, E. Sidransky, N. Tayebi, P. Wild Crea, C. Blauwendraat, H. Houlden, J. Hardy, A. Singleton, N. Okubadejo (London, United Kingdom)

    Objective: To provide a genome-wide association study (GWAS)- based insight into the genetics of Parkinson’s disease (PD) in Africans and African admixed populations. Background: Understanding…
  • « Previous Page
  • 1
  • …
  • 230
  • 231
  • 232
  • 233
  • 234
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • An atypical and interesting feature of Parkinson´s disease
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley